Zhejiang Int'l Group Co., Ltd. (000411) Stock Analysis | Price, Returns, Financials & Key Metrics

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Dashboard

High Debt Company with a Debt to Equity ratio (avg) at times

Poor long term growth as Net Sales has grown by an annual rate of 6.21% and Operating profit at 10.28% over the last 5 years
High Debt Company with a Debt to Equity ratio (avg) at times
The company has been able to generate a Return on Equity (avg) of 16.05% signifying low profitability per unit of shareholders funds

Poor long term growth as Net Sales has grown by an annual rate of 6.21% and Operating profit at 10.28% over the last 5 years

With ROE of 12.74%, it has a attractive valuation with a 0.70 Price to Book Value

Underperformed the market in the last 1 year

Mojo Parameters

Stock DNA

Industry

Pharmaceuticals & Biotechnology

Market cap

CNY 3,276 Million (Mid Cap)

P/E

5.00

Industry P/E

Dividend Yield

5.91%

Debt Equity

0.81

Return on Equity

12.74%

Price to Book

0.70

Revenue and Profits:

Net Sales:

8,173 Million

(Quarterly Results - Jun 2025)

Net Profit:

169 Million

Total Returns

Total Returns (Price + Dividend)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

10.45%

6 Months

14.96%

1 Year

12.91%

2 Years

4.62%

3 Years

-4.66%

4 Years

19.81%

5 Years

-23.81%

Zhejiang Int'l Group Co., Ltd. for the last several years.

Risk Adjusted Returns v/s

News & Corporate Actions

News

No Recent News for the Company

Announcements

No announcement available

Corporate Actions

No corporate action available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

6.21%

EBIT Growth (5y)

10.28%

EBIT to Interest (avg)

4.91

Debt to EBITDA (avg)

4.05

Net Debt to Equity (avg)

0.97

Sales to Capital Employed (avg)

3.51

Tax Ratio

24.16%

Dividend Payout Ratio

37.57%

Pledged Shares

Institutional Holding

ROCE (avg)

11.23%

ROE (avg)

16.05%

Valuation key factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

0.70

EV to EBIT

7.74

EV to EBITDA

6.30

EV to Capital Employed

0.83

EV to Sales

0.21

PEG Ratio

0.59

Dividend Yield

5.91%

ROCE (Latest)

10.78%

ROE (Latest)

12.74%

Technicals key factors

Indicator

Weekly

Monthly

MACD

Bullish

RSI

No Signal

Bollinger Bands

Bullish

Moving Averages

Bullish (Daily)

KST

Bullish

Dow Theory

Mildly Bullish

OBV

Bullish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot

No data for shareholding present.

Shareholding Compare (%holding)

No data for shareholding present.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Jun 2025 is -2.88% vs -1.61% in Mar 2025",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Jun 2025 is 42.07% vs -38.07% in Mar 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Jun'25",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "8,173.30",
          "val2": "8,415.90",
          "chgp": "-2.88%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "315.00",
          "val2": "249.80",
          "chgp": "26.10%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "40.60",
          "val2": "37.10",
          "chgp": "9.43%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "169.20",
          "val2": "119.10",
          "chgp": "42.07%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "32.10%",
          "val2": "23.40%",
          "chgp": "0.87%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is 4.04% vs 4.67% in Dec 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is 3.94% vs 27.15% in Dec 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "33,275.90",
          "val2": "31,983.20",
          "chgp": "4.04%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "1,124.60",
          "val2": "1,014.70",
          "chgp": "10.83%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "155.30",
          "val2": "162.40",
          "chgp": "-4.37%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.10",
          "val2": "-0.50",
          "chgp": "120.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "611.90",
          "val2": "588.70",
          "chgp": "3.94%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "27.70%",
          "val2": "26.40%",
          "chgp": "0.13%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ

Jun'25

Mar'25

Change(%)

Net Sales

8,173.30

8,415.90

-2.88%

Operating Profit (PBDIT) excl Other Income

315.00

249.80

26.10%

Interest

40.60

37.10

9.43%

Exceptional Items

0.00

Consolidate Net Profit

169.20

119.10

42.07%

Operating Profit Margin (Excl OI)

32.10%

23.40%

0.87%

USD in Million.

Compare with Peers

Net Sales

QoQ Growth in quarter ended Jun 2025 is -2.88% vs -1.61% in Mar 2025

Consolidated Net Profit

QoQ Growth in quarter ended Jun 2025 is 42.07% vs -38.07% in Mar 2025

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'24

Dec'24

Dec'23

Change(%)

Net Sales

33,275.90

31,983.20

4.04%

Operating Profit (PBDIT) excl Other Income

1,124.60

1,014.70

10.83%

Interest

155.30

162.40

-4.37%

Exceptional Items

0.10

-0.50

120.00%

Consolidate Net Profit

611.90

588.70

3.94%

Operating Profit Margin (Excl OI)

27.70%

26.40%

0.13%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2024 is 4.04% vs 4.67% in Dec 2023

Consolidated Net Profit

YoY Growth in year ended Dec 2024 is 3.94% vs 27.15% in Dec 2023

All Annual Results

Company CV

About Zhejiang Int'l Group Co., Ltd.

Zhejiang Int'l Group Co., Ltd.

Pharmaceuticals & Biotechnology

No Details Available.

Company Coordinates

No Company Details Available